GeneCell International
GeneCell International is a private, Doral, Florida-based service provider that processes and cryogenically stores newborn cord blood for expectant parents and families, operating with 1-10 employees and no disclosed funding or partnerships.
- Company typePrivate
- Founded-
- HeadquartersDoral, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What GeneCell International does
GeneCell International is a private, for-profit company headquartered in Doral, Florida, that provides processing and cryogenic storage services for child cord blood banking. Its functional role in the value chain is the collection, processing, and long-term storage of hematopoietic stem cells harvested from umbilical cord blood at birth, serving expectant parents and families who elect to privately bank newborn biological material.
The company's product surface is a service offering — physical cryogenic storage backed by laboratory processing — rather than a software or technology product. The underlying operations depend on regulated tissue-handling infrastructure (cryogenic tanks, sterile processing facilities, chain-of-custody protocols) and the relevant regulatory frameworks (FDA, AABB or equivalent accrediting bodies), although the source data does not surface specific certifications, accreditations, or facility details. No proprietary technology, patents, or differentiated processing methods are disclosed.
GeneCell International's business model is presumed to be a hybrid of an upfront processing/enrollment fee plus recurring annual storage fees, consistent with industry-standard cord blood banking economics. Pricing, contract terms, channel mix (direct-to-consumer vs. hospital/OB-GYN referral vs. partnership), and customer acquisition mechanics are not disclosed in the available source material, and the company's primary web property (genecell.com) is currently gated behind a verification/loading checkpoint and does not render substantive commercial content. With 1-10 employees and no disclosed funding, partnerships, or growth signals, the firm operates as a small-scale, privately held service provider.
GeneCell International firmographics
Firmographics- Name
- GeneCell International
- Website
- https://genecell.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- GeneCell International is a private, Doral, Florida-based service provider that processes and cryogenically stores newborn cord blood for expectant parents and families, operating with 1-10 employees and no disclosed funding or partnerships.
- Ownership category
- akta.pro rank
GeneCell International industry classification
Industry- Product category
- Cord Blood Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where GeneCell International is headquartered
LocationHeadquarters
- HQ city
- Doral
- HQ country
- United States
- HQ region
- North America
Markets served
GeneCell International business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Infrastructure, Marketing or Sales, Supply Chain
GeneCell International product offering
Product offeringCore offering
GeneCell International provides processing and cryogenically storing services for a child's cord blood. The company collects, processes, and cryogenically preserves umbilical cord blood and stem cells from newborns for potential future medical use by the donor family. Services are offered to expectant parents on a private/family banking basis.
Differentiator
Problem solved
Functional benefit
Products and services
- Private Cord Blood Banking Collection kit, processing, and long-term cryogenic storage of a newborn's umbilical cord blood stem cells for the donor family, offered to expectant parents as a private/family banking service.
Companies that use GeneCell International
Customer profileIdeal customer profiles1 record
GeneCell International technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
GeneCell International competitors and assessment
Company assessmentDirect peers
- Cord Blood Registry (CBR): One of the largest U.S. family cord blood banks, offering the same core service of umbilical cord blood collection, processing, and cryogenic storage that GeneCell provides.
- ViaCord (Revvity): Family cord blood banking service attached to a large life sciences platform, providing directly competing cord blood and cord tissue collection and cryogenic storage services.
- New England Cord Blood Bank: Regional U.S. cord blood bank that processes and cryogenically stores both family and donor cord blood units, overlapping directly with GeneCell's service model.
- StemCyte: Cord blood bank operating both family storage and public donation programs, competing head-to-head with GeneCell on collection, processing, and long-term storage.
- Cryo-Cell International: Public, Florida-based family cord blood banking company offering processing and long-term cryogenic storage directly comparable to GeneCell's service, including geographically overlapping the South Florida market.
- LifebankUSA: Cord blood and placental stem cell banking service with overlapping collection-and-store model and similar expectant-parent customer base.
- CorCell: Family cord blood banking service focused on collection kits, processing, and cryogenic storage; directly comparable offering and target customer to GeneCell.
Broad incumbents
- BioLife Solutions: Supplier of cryopreservation media, storage solutions, and cold-chain tools used widely across the cell and tissue banking industry, an adjacent incumbent whose products underpin GeneCell's storage operations.
Regional players
- Cells for Life: Canadian family cord blood bank providing the same processing and cryogenic storage service in a different geography, useful as a benchmark for unit economics in the cord blood banking category.
- Future Health Biobank: UK-based stem cell and cord tissue storage bank operating a parallel private banking model across multiple geographies; comparable as a private-pay family banking operator.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights3 records
Customer concentration
GeneCell International social profiles
Digital presenceGeneCell International financial estimates
Financial estimateRevenue estimate
Valuation estimate
GeneCell International leadership team
Management profileNumber of profiles
GeneCell International funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GeneCell International M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GeneCell International
What does GeneCell International do?
GeneCell International provides processing and cryogenically storing services for a child's cord blood. The company collects, processes, and cryogenically preserves umbilical cord blood and stem cells from newborns for potential future medical use by the donor family. Services are offered to expectant parents on a private/family banking basis.
Is GeneCell International a public or private company?
GeneCell International is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GeneCell International founded?
GeneCell International was founded in -1. It employs 1 to 10 people.
Where is GeneCell International based?
GeneCell International is headquartered in Doral, United States, in the North America region.
Who are GeneCell International's main competitors?
Direct peers on record are Cord Blood Registry (CBR), ViaCord (Revvity), New England Cord Blood Bank, StemCyte, Cryo-Cell International, LifebankUSA and CorCell. BioLife Solutions is listed as a broad incumbent. Regional players are Cells for Life and Future Health Biobank.
Does GeneCell International have an API?
No public API is recorded for GeneCell International.
What industry is GeneCell International in?
GeneCell International's product category is Cord Blood Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.